MAPT and frontotemporal dementia: Pathologically, in both familial and sporadic FTD, three main protein biomarkers have been identified: TDP–43, fused in sarcoma (FUS), and tau (structural proteins predominantly found supporting the stability of cerebral axonal microtubules) [21,22].